• 1. Emergence of cationic polyamine dendrimersomes: design, stimuli sensitivity and potential biomedical applications
  Partha Laskar,Christine Dufès Nanoscale Adv., 2021,3, 6007-6026
• 2. Fe3O4/PEG-SO3H as a heterogeneous and magnetically-recyclable nanocatalyst for the oxidation of sulfides to sulfones or sulfoxides
  Saeideh Mirfakhraei,Malak Hekmati,Fereshteh Hosseini Eshbala,Hojat Veisi New J. Chem., 2018,42, 1757-1761
• 3. Estimation of activation energy for electroporation and pore growth rate in liquid crystalline and gel phases of lipid bilayers using molecular dynamics simulations?
  Amit Kumar Majhi,Subbarao Kanchi,V. Venkataraman,K. G. Ayappa,Prabal K. Maiti Soft Matter, 2015,11, 8632-8640
• 4. Fe3O4 nanoparticle chains with N-doped carbon coating: magnetotactic bacteria assisted synthesis and high-rate lithium storage?
  Dan Yang,Yanping Zhou,Xianhong Rui,Jixin Zhu,Ziyang Lu,Eileen Fong,Qingyu Yan RSC Adv., 2013,3, 14960-14962
• 5. Emulsifier-free, organotellurium-mediated living radical emulsion polymerization (emulsion TERP) of styrene: poly(dimethylaminoethyl methacrylate) macro-TERP agent?
  Yukiya Kitayama Polym. Chem., 2014,5, 2784-2792

Research Brief on 1,1-Dimethylethyl 4-(3-bromocyclobutyl)-1-piperidinecarboxylate (CAS: 2803859-63-2)

1,1-Dimethylethyl 4-(3-bromocyclobutyl)-1-piperidinecarboxylate (CAS: 2803859-63-2) is a specialized chemical compound that has recently garnered attention in the field of chemical biology and pharmaceutical research. This compound, characterized by its unique cyclobutyl and piperidine moieties, serves as a critical intermediate in the synthesis of novel bioactive molecules. Recent studies have explored its potential applications in drug discovery, particularly in the development of small-molecule inhibitors targeting various disease pathways.

The compound's structural features, including the bromocyclobutyl group, make it a versatile building block for medicinal chemistry. Researchers have utilized it in the synthesis of compounds with potential therapeutic effects, such as kinase inhibitors and modulators of G-protein-coupled receptors (GPCRs). Its role in facilitating the construction of complex molecular architectures has been highlighted in several recent publications, underscoring its importance in modern drug development.

One of the key areas of investigation has been the optimization of synthetic routes for 1,1-Dimethylethyl 4-(3-bromocyclobutyl)-1-piperidinecarboxylate. Recent advancements in catalytic methods and green chemistry have enabled more efficient and scalable production of this compound, addressing previous challenges related to yield and purity. These improvements are critical for its broader application in high-throughput screening and lead optimization processes.

In addition to its synthetic utility, the compound has been studied for its biological activity. Preliminary in vitro assays suggest that derivatives of 1,1-Dimethylethyl 4-(3-bromocyclobutyl)-1-piperidinecarboxylate exhibit promising activity against certain cancer cell lines and inflammatory targets. These findings have spurred further research into its mechanism of action and potential as a scaffold for drug candidates.

Looking ahead, the continued exploration of 1,1-Dimethylethyl 4-(3-bromocyclobutyl)-1-piperidinecarboxylate and its derivatives is expected to yield significant insights into its therapeutic potential. Collaborative efforts between academic and industrial researchers are likely to accelerate the translation of these discoveries into clinical applications, paving the way for new treatments in oncology, immunology, and beyond.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)